Device Trial Radar · NCT05768295
Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 Implants
Last checked: Nov 19, 2026Latest source record: Mar 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Apr 5, 2023
Primary completion
Aug 20, 2025
Study completion Jul 2027
Sponsor
- Lead sponsor
- AnthogyrNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 14, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Post-Market Clinical Follow-Up study aims to document the success and survival of the Axiom® BL X3 Implants up to 3 years after loading.
Conditions
- Surgical Operation
- Edentulous Jaw
- Edentulous Mouth
- Implant
Interventions
Axiom BL X3Device
collecting data on the use of Axiom BL X3 and patient satisfaction
Primary outcomes
What the sponsor says the trial is designed to measure.
- Implant success rateTime frame: 3 years after loading
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Cabinet Dentaire Les Aravis
Annecy, France
Cabinet Dr Fumery
Beauvais, France
Cabinet Dr Vigouroux
Cadaujac, France
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.